Question for you, BDAZ.  

Once the Phase 3 dosing ends, it will take them 2 months to get adjudicated on the MACE events.  They will have 2 months to do a lot of data analysis...so I assume a lot of the prelim results will be known.  

After those 2 months, is that when ALL the key findings be announced with the top line data?  In other words, after the top line data is announced, is the remaining data analysis more about crossing the t s and dotting the i s?  Or is there more information that can be gleaned from the data, that the prelim data analysis won't uncover?

Thanks!